The melatonin agonist ramelteon induces duration-dependent clock gene expression through cAMP signaling in pancreatic INS-1 β-cells.
Prolonged exposure to melatonin improves glycemic control in animals. Although glucose metabolism is controlled by circadian clock genes, little is known about the role of melatonin signaling and its duration in the regulation of clock gene expression in pancreatic β-cells. Activation of MT1 and MT2...
Main Authors: | Keiji Nishiyama, Keisuke Hirai |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4094524?pdf=render |
Similar Items
-
Ramelteon: A melatonin receptor agonist for the treatment of insomnia
by: Devi V, et al.
Published: (2008-01-01) -
Melatonin and Its Agonist Ramelteon in Alzheimer's Disease: Possible Therapeutic Value
by: Venkatramanujam Srinivasan, et al.
Published: (2011-01-01) -
The Melatonin Receptor Agonist Ramelteon Effectively Treats Insomnia and Behavioral Symptoms in Autistic Disorder
by: Kentaro Kawabe, et al.
Published: (2014-01-01) -
The regulation of circadian clock genes and Ramelteon treatment in patients with anxiety and depression
by: Yu-Chuan Chien, et al.
Published: (2018) -
Melatonin receptor agonists—ramelteon and melatonin—for bipolar disorder: a systematic review and meta-analysis of double-blind, randomized, placebo-controlled trials
by: Kishi T, et al.
Published: (2019-05-01)